2010 - 2011 SEMINAR SERIES 10:00am - 11:00am -- H363 Title of presentation
Goal directed therapy in postoperative cardiac surgery - which targets ?
Critical Care Medicine, SMBD - Jewish General Hospital and Montreal Chest Institute, Respiratory Epidemiology and Clinical Research Unit, McGill University
Tuesday, October 12, 2010 Ilan Matok, MScPharm PhD
The BeMORE Collaboration - Using Computerized Databases To Study Drugs
Research Fellow, Division of Clinical Pharmacology & Safety During PregnancyToxicologyThe Hospital for Sick Children, Toronto, Ontario
Tuesday, October 19, 2010 Lucie Blais, PhD
Asthma medications in pregnancy and the risk of congenital malformations
Professeure titulaireChaire AstraZeneca en santé respiratoireFaculté de pharmacieUniversité de Montréal
Tuesday, October 26, 2010 Samy Suissa, PhD
Immortal time bias in observational studies of drug effectiveness
James McGill Professor of Epidemiology, Biostatistics and Medicine, McGill UniversityDirector, Centre for Clinical EpidemiologyLady Davis Institute for Medical Research - Jewish General Hospital
Evolution in the local treatment of rectal cancer
Associate Professor, Department of Oncology, McGill UniversityDirector, Department of Radiation Oncology, Segal Cancer CentreAssistant Chair of Radiation Oncology, McGill University
Title of presentation
Tuesday, November 09, 2010Anick Bérard, PhD
The Quebec Pregnancy Registry - An opportunity for research in perinatal
Director, Research Unit on Medications and Pregnancy pharmacoepidemiologyResearch Center CHU Ste-JustineLouis-Boivin Family Research Chair on Medications, Pregnancy and LactationAssociate Professor, Faculty of Pharmacy, University of MontrealPresident-Elect, Canadian Association for Population Therapeutics
Tuesday, November 16, 2010Jim Hanley, PhD
Measuring mortality reductions in cancer screening trials
Professor, Department of Epidemiology, Biostatistics and Occupational Health,McGill University
Tuesday, November 23, 2010Michael Pollak, MD
Professor, Department of Medicine & Oncology, McGill UniversityDirector, Cancer Prevention Centre, SMBD-Jewish General HospitalAlexander Goldfarb Research Chair in Medical Oncology
Tuesday, November 30, 2010Dr. Bluma Brenner
HIV-1 prevention based on molecular epidemiological surveillance of HIV
Assistant Professor, Faculty of Surgery (Medicine),
McGill UniversityMember, McGill AIDS CentreCo-Coordinator of the Quebec Genotyping ProgramDirector of the Axe de résistance/pathogenèse of the Quebec FRSQ SIDA Network
Title of presentation
Tuesday, January 18, 2011 Ian Shrier, MD PhD Dip Sport Med
A Causal Diagram Approach to Evidence Synthesis
Associate Professor, Department of Family Medicine, McGill UniversityPast-President, Canadian Academy of Sport MedicineInvestigator, Centre for Clinical Epidemiology,SMBD-Jewish General Hospital, LDI
Tuesday, January 25, 2011 Mark Wainberg, PhD
Sexual Transmission of Drug-Resistant Variants of HIV in Canada and in
Developing Countries: Implications for Public Health
Lady Davis Institute for Medical Research,Director of the McGill University AIDS Centre
Tuesday, February 01, 2011 Helen Trottier, PhD
Human Papillomavirus re-infection with the same or a different genotype: the role
Assistant Professor, Department of Social and
Preventive Medicine, University of Montreal;Researcher, CHU Sainte-Justine Research Center
Tuesday, February 08, 2011 Jacques Le Lorier, MD PhD FRCPC FISPE
Professor, Departments of Medicine and PharmacologyFaculty of Medicine, University of Montreal;Chief, Pharmacoepidemiology and Pharmacoeconomy
Family caregiving for people at the end of life:
Tuesday, February 22, 2011 Brett Thombs, PhD
The reporting of conflicts of interest in meta-analyses
Department of Psychiatry, Lady Davis Institute for Medical Research andMcGill University
The Michel Saucier Endowed Chair in Geriatric
Pharmacology, Health and AgingAssociate Professor of Medicine University of Montreal, Head, Health Services and Health Promotion research axisCentre de Recherche Institut Universitaire de Gériatrie de Montréal
Professor of Medicine, McGill University
Development and validation of a clinical prediction
Director, Thrombosis Fellowship, McGill University and rule for recurrent venous thromboembolismThrombosis Program, Jewish General Hospital, Division of Internal Medicine, and Centre for Clinical Epidemiology
Director, McGill University Office for Science and Society
Assistant ProfessorDepartment of Medicine, Faculty Member, Division of Clinical EpidemiologyMcGill University Health Centre
CARTaGENE – An infrastructure for research in
Findings from screening studies: when do we know enough to implement a new
Departments of Obstetrics & Gynecology and
(The example of HPV testing for cervical cancer)
Preventive & Social Medicine Research Centre, Centre Hospitalier de l'Université de Montréal
Long term outcome in ADHD and predictors of outcome
Professor of Psychiatry and Pediatrics, Director of Research, Division of Child Psychiatry, McGill University, Montreal Children's Hospital
Relationship between Adherence Level to Antihypertensive
Agents and Clinical Issues and Healthcare Costs in Real Life
Faculté de Pharmacie, Université de MontréalChaire Sanofi Aventis sur l'utilisation des médicaments
12 POSTÊPOWANIE PRZECIWBÓLOWE W URAZACH Ewa Mayzner-Zawadzka, Beata B³aszyk,Wojciech Serednicki, Jan Dobrogowski, Jerzy Wordliczek,Andrzej Zawadzki Obra¿enia cia³a stanowi¹ obecnie jeden z najpowa¿niejszych proble-mów medycznych. S¹ one trzeci¹, co do czêstoœci, przyczyn¹ zgonów,a drug¹, co do czêstoœci, przyczyn¹ niezdolnoœci do pracy. W Polsce wskaŸnik urazowoœci wyno
American Society for Clinical Pharmacology and Therapeutics RIMONABANT PHARMACOKINETICS IN HEALTHY ANDCYP3A5 BUT NOT CYP2D6 POLYMORPHISM AFFECTSOBESE SUBJECTS. S. Turpault, V. Kanamaluru, G. F. Lockwood,DEXTROPROPOXYPHENE DISPOSITION IN HUMAN SUB-D. Bonnet, J. Newton, sanofi-aventis, Malvern, PA. JECTS. M. S. Chow, PharmD, O. Q. Yin, PhD, B. Tomlinson, MD, BACKGROUND: Rimonabant is the fi